Critical Appraisal of PD-L1 Expression as a Predictive Biomarker for EGFR-TKI Efficacy in Lung Squamous Cell Carcinoma

American Journal of Therapeutics 2026

View at publisher

Authors: Ghulam Mustafa

DOI: 10.1097/mjt.0000000000002115

Cited by: 0

References: 2

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

References 2